Alkemy Research Development vs Selling And Marketing Expenses Analysis

ALK Stock

130.00 5.00 4.00%

Alkemy Capital financial indicator trend analysis is way more than just evaluating Alkemy Capital Inves prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alkemy Capital Inves is a good investment. Please check the relationship between Alkemy Capital Research Development and its Selling And Marketing Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkemy Capital Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alkemy Capital Inves Research Development account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Alkemy Capital's Research Development and Selling And Marketing Expenses is 0.92. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Alkemy Capital Investments, assuming nothing else is changed. The correlation between historical values of Alkemy Capital's Research Development and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Alkemy Capital Investments are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Research Development i.e., Alkemy Capital's Research Development and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Selling And Marketing Expenses

Most indicators from Alkemy Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alkemy Capital Inves current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkemy Capital Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Tax Provision is expected to grow to about (308.8 K). In addition to that, Selling General Administrative is expected to decline to about 805.3 K

	2010	2022	2023	2024 (projected)
Total Operating Expenses	797.7K	2.6M	1.5M	1.8M
Cost Of Revenue	330.75	1.3K	634.3K	666.0K

Total Operating Expenses Cost Of Revenue

Alkemy Capital fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Common Stock	Short Long Term Debt Total	Net Tangible Assets	Net Receivables	Inventory	Net Working Capital	Short Term Debt	Intangible Assets	Current Deferred Revenue
Total Assets		0.81	0.98	-0.99	1.0	-0.94	0.77	-1.0	-1.0	0.72	0.28	-0.06	0.92	0.98	-0.37	0.99	0.95	0.98	-0.58	-0.8	0.77	-0.54	-0.8	-0.58	0.54	0.57
Other Current Liab	0.81		0.88	-0.88	0.83	-0.59	0.26	-0.78	-0.78	0.19	0.7	-0.61	0.67	0.88	0.17	0.86	0.6	0.69	-0.04	-0.34	0.42	-0.11	-0.36	-0.04	0.11	0.04
Total Current Liabilities	0.98	0.88		-1.0	0.99	-0.88	0.67	-0.98	-0.98	0.61	0.41	-0.23	0.85	1.0	-0.3	1.0	0.89	0.92	-0.43	-0.74	0.75	-0.47	-0.75	-0.43	0.47	0.42
Total Stockholder Equity	-0.99	-0.88	-1.0		-0.99	0.88	-0.69	0.98	0.98	-0.61	-0.42	0.2	-0.87	-1.0	0.3	-1.0	-0.9	-0.93	0.44	0.74	-0.75	0.44	0.75	0.44	-0.44	-0.44
Net Debt	1.0	0.83	0.99	-0.99		-0.93	0.75	-1.0	-1.0	0.69	0.31	-0.11	0.91	0.99	-0.36	1.0	0.94	0.97	-0.53	-0.79	0.77	-0.53	-0.79	-0.53	0.53	0.53
Retained Earnings	-0.94	-0.59	-0.88	0.88	-0.93		-0.88	0.96	0.96	-0.9	0.06	-0.21	-0.95	-0.88	0.52	-0.9	-0.98	-0.98	0.8	0.87	-0.74	0.77	0.86	0.8	-0.77	-0.8
Accounts Payable	0.77	0.26	0.67	-0.69	0.75	-0.88		-0.79	-0.79	0.96	-0.21	0.56	0.77	0.67	-0.81	0.7	0.92	0.86	-0.85	-0.96	0.85	-0.67	-0.95	-0.85	0.67	0.85
Cash	-1.0	-0.78	-0.98	0.98	-1.0	0.96	-0.79		1.0	-0.76	-0.22	0.03	-0.93	-0.98	0.4	-0.99	-0.96	-0.98	0.61	0.82	-0.77	0.6	0.82	0.61	-0.6	-0.61
Cash And Short Term Investments	-1.0	-0.78	-0.98	0.98	-1.0	0.96	-0.79	1.0		-0.76	-0.22	0.03	-0.93	-0.98	0.4	-0.99	-0.96	-0.98	0.61	0.82	-0.77	0.6	0.82	0.61	-0.6	-0.61
Common Stock Shares Outstanding	0.72	0.19	0.61	-0.61	0.69	-0.9	0.96	-0.76	-0.76		-0.42	0.6	0.79	0.61	-0.76	0.64	0.89	0.83	-0.94	-0.91	0.73	-0.84	-0.88	-0.94	0.84	0.94
Non Current Liabilities Total	0.28	0.7	0.41	-0.42	0.31	0.06	-0.21	-0.22	-0.22	-0.42		-0.78	0.02	0.41	0.37	0.38	0.03	0.1	0.58	0.11	0.15	0.57	0.06	0.58	-0.57	-0.58
Other Current Assets	-0.06	-0.61	-0.23	0.2	-0.11	-0.21	0.56	0.03	0.03	0.6	-0.78		0.13	-0.23	-0.65	-0.18	0.24	0.13	-0.71	-0.39	0.2	-0.39	-0.36	-0.71	0.39	0.71
Other Stockholder Equity	0.92	0.67	0.85	-0.87	0.91	-0.95	0.77	-0.93	-0.93	0.79	0.02	0.13		0.85	-0.28	0.88	0.94	0.96	-0.77	-0.71	0.56	-0.63	-0.69	-0.77	0.63	0.77
Total Liab	0.98	0.88	1.0	-1.0	0.99	-0.88	0.67	-0.98	-0.98	0.61	0.41	-0.23	0.85		-0.3	1.0	0.89	0.92	-0.43	-0.74	0.75	-0.47	-0.75	-0.43	0.47	0.42
Net Invested Capital	-0.37	0.17	-0.3	0.3	-0.36	0.52	-0.81	0.4	0.4	-0.76	0.37	-0.65	-0.28	-0.3		-0.32	-0.56	-0.45	0.6	0.85	-0.82	0.58	0.85	0.6	-0.58	-0.6
Total Current Assets	0.99	0.86	1.0	-1.0	1.0	-0.9	0.7	-0.99	-0.99	0.64	0.38	-0.18	0.88	1.0	-0.32		0.91	0.94	-0.47	-0.76	0.76	-0.49	-0.77	-0.47	0.49	0.47
Capital Stock	0.95	0.6	0.89	-0.9	0.94	-0.98	0.92	-0.96	-0.96	0.89	0.03	0.24	0.94	0.89	-0.56	0.91		0.99	-0.77	-0.9	0.81	-0.65	-0.89	-0.77	0.65	0.77
Common Stock	0.98	0.69	0.92	-0.93	0.97	-0.98	0.86	-0.98	-0.98	0.83	0.1	0.13	0.96	0.92	-0.45	0.94	0.99		-0.73	-0.85	0.76	-0.63	-0.84	-0.73	0.63	0.73
Short Long Term Debt Total	-0.58	-0.04	-0.43	0.44	-0.53	0.8	-0.85	0.61	0.61	-0.94	0.58	-0.71	-0.77	-0.43	0.6	-0.47	-0.77	-0.73		0.73	-0.47	0.8	0.69	1.0	-0.8	-1.0
Net Tangible Assets	-0.8	-0.34	-0.74	0.74	-0.79	0.87	-0.96	0.82	0.82	-0.91	0.11	-0.39	-0.71	-0.74	0.85	-0.76	-0.9	-0.85	0.73		-0.95	0.71	1.0	0.73	-0.71	-0.73
Net Receivables	0.77	0.42	0.75	-0.75	0.77	-0.74	0.85	-0.77	-0.77	0.73	0.15	0.2	0.56	0.75	-0.82	0.76	0.81	0.76	-0.47	-0.95		-0.49	-0.96	-0.47	0.49	0.47
Inventory	-0.54	-0.11	-0.47	0.44	-0.53	0.77	-0.67	0.6	0.6	-0.84	0.57	-0.39	-0.63	-0.47	0.58	-0.49	-0.65	-0.63	0.8	0.71	-0.49		0.67	0.8	-1.0	-0.8
Net Working Capital	-0.8	-0.36	-0.75	0.75	-0.79	0.86	-0.95	0.82	0.82	-0.88	0.06	-0.36	-0.69	-0.75	0.85	-0.77	-0.89	-0.84	0.69	1.0	-0.96	0.67		0.69	-0.67	-0.69
Short Term Debt	-0.58	-0.04	-0.43	0.44	-0.53	0.8	-0.85	0.61	0.61	-0.94	0.58	-0.71	-0.77	-0.43	0.6	-0.47	-0.77	-0.73	1.0	0.73	-0.47	0.8	0.69		-0.8	-1.0
Intangible Assets	0.54	0.11	0.47	-0.44	0.53	-0.77	0.67	-0.6	-0.6	0.84	-0.57	0.39	0.63	0.47	-0.58	0.49	0.65	0.63	-0.8	-0.71	0.49	-1.0	-0.67	-0.8		0.8
Current Deferred Revenue	0.57	0.04	0.42	-0.44	0.53	-0.8	0.85	-0.61	-0.61	0.94	-0.58	0.71	0.77	0.42	-0.6	0.47	0.77	0.73	-1.0	-0.73	0.47	-0.8	-0.69	-1.0	0.8

Click cells to compare fundamentals

Alkemy Capital Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Alkemy Stock

Balance Sheet is a snapshot of the financial position of Alkemy Capital Inves at a specified time, usually calculated after every quarter, six months, or one year. Alkemy Capital Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Alkemy Capital and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Alkemy currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Alkemy Research Development vs Selling And Marketing Expenses Analysis

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Research Development

Selling And Marketing Expenses

Alkemy Capital fundamental ratios Correlations

Alkemy Capital Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Other Information on Investing in Alkemy Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Total Liab

Current Deferred Revenue	- 1.0	Short Term Debt
Intangible Assets	- 1.0	Inventory
Current Deferred Revenue	- 1.0	Short Long Term Debt Total
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Total Current Assets	- 1.0	Total Stockholder Equity